Increased serum concentration of nerve growth factor in patients with microprolactinoma

Neuropeptides

Volumn 38, Issue 1, 2004, Pages 21-24

  Sigala, Sandra ^a   Martocchia, Antonio ^b   Missale, Cristina ^a   Falaschi, Paolo ^b   Spano, Pierfranco ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Dopamine D 2 agonists; Nerve growth factor; Prolactin; Prolactinoma

Indexed keywords

CABERGOLINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; MESSENGER RNA; NERVE GROWTH FACTOR; PROLACTIN; PROTIRELIN;

ADULT; ARTICLE; CASE REPORT; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; FEMALE; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; IN VIVO STUDY; LACTATION; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; PREGNANCY; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTIN SECRETING CELL; PROLACTINOMA; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN SECRETION;

ANIMALIA;

EID: 1642388630     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2003.11.002     Document Type: Article

References (14)

1. Alleva, E., Aloe, L., Cirulli, F., Della Seta, D., Tirassa, A., 1996. Serum NGF levels increase during lactation and following maternal aggression in mice. Physiology and Behavior 59, 461-466.
2. Faglia, G., 1998. The clinical impact of the thyrotropin-releasing hormone test. Thyroid 8, 903-907.
3. Goffin, V., Binart, N., Touraine, P., Kelly, P.A., 2002. Prolactin: the new biology of an old hormone. Annual Review of Physiology 64, 47-67.
4. Lathinen, T., Soinila, S., Lakshanan, J., 1989. Biological demonstration of nerve growth factor in rat pituitary gland. Neuroscience 30, 165-170.
5. Levi-Montalcini, R., Skaper, S.D., Dal Toso, R., Petrelli, L., Leon, A., 1996. Nerve growth factor: from neurotrophin to neurokine. Trends in Neuroscience 19, 514-520.
6. Luppi, P., Levi-Montalcini, R., Bracci-Laudiero, L., Bertolini, A., Arletti, R., Tavernari, D., Vigneti, E., Aloe, L., 1993. NGF is released into plasma during human pregnancy: an oxytocin-mediated response. NeuroReport 4, 1063-1065.
7. Martocchia, A., Sigala, S., Proietti, A., D'Urso, R., Spano, P.P., Missale, C., Falaschi, P., 2002. Sex-related variations in serum Nerve Growth Factor concentrations in humans. Neuropeptides 36, 391-395.
8. Missale, C., Boroni, F., Losa, M., Giovanelli, M., Zanellato, A., Dal Toso, R., Spano, P.F., 1993. Nerve Growth Factor suppresses the trasforming phenotype of human prolactinomas. Proceedings of the National Academy of Sciences of the United States of America 90, 7961-7965.
9. Missale, C., Boroni, F., Frassine, M., Caruso, A., Spano, P.F., 1995. Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro. Endocrinology 136, 1205-1213.
10. Missale, C., Boroni, F., Sigala, S., Buriani, A., Leon, A., Dal Toso, R., Spano, P.F., 1996a. Nerve Growth Factor in the anterior pituitary: Localization in mammotroph cells and cosecretion with prolactin by a dopamine-regulated mechanism. Proceedings of the National Academy of Sciences of the United States of America USA 93, 4240-4245.
11. Missale, C., Losa, M., Sigala, S., Balsari, A., Giovanelli, M., Spano, P.F., 1996b. Nerve Growth Factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism. Molecular Endocrinology 10, 272-285.
12. Missale, C., Spano, P.F., 1998. Nerve Growth Factor in pituitary development and pituitary tumors. Frontiers in Neuroendocrinology 19, 128-150.
13. Patterson, J.C., Childs, G.W., 1994. Nerve growth factor and its receptors in the anterior pituitary. Endocrinology 135, 1689-1696.
14. Skaper, S.D., 2001. Nerve Growth Factor: a neurokine orchestrating neuroimmune-endocrine functions. Molecular Neurobiology 24, 183-199.